drugset / Trial / NCT04746222
Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization
Phase 2/3
Unknown
108 enrolled
Tan Tock Seng Hospital
Singapore Clinical Research Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double-blinded, randomised controlled trial to evaluate the clinical efficacy of a single dose of oral capsule-administered faecal microbiota transplantation (FMT) for carbapenemase-producing Enterobacteriaceae (CPE) intestinal decolonisation compared with placebo. Primary outcome is the proportion of patients successfully decolonised of CPE intestinal carriage at 12 weeks after FMT treatment compared with placebo.
Timeline
- Start
- 2021-07
- Primary completion
- 2022-10
- Completion
- 2023-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oral capsule faecal microbiota transplantation | Unknown | 30 unknown | Oral |
Indications
No indication recorded.